Clinical Trial Detail

NCT ID NCT01871766
Title Treatment of Localized Rhabdomyosarcoma With Chemotherapy, Radiotherapy, and Surgery
Recruitment Suspended
Gender both
Phase Phase II
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications

rhabdomyosarcoma

Therapies

Bevacizumab + Cyclophosphamide + Sorafenib

Dactinomycin + Vincristine Sulfate

Cyclophosphamide + Dactinomycin + Vincristine Sulfate

Age Groups: adult child

No variant requirements are available.